Skip to content
LexBuild

Availability for Non-Exclusive, Exclusive, or Partially Exclusive Licensing of U.S. Patent Application Concern Antifungal and Antiparasitic Compounds

---
identifier: "/us/fr/01-19763"
source: "fr"
legal_status: "authoritative_unofficial"
title: "Availability for Non-Exclusive, Exclusive, or Partially Exclusive Licensing of U.S. Patent Application Concern Antifungal and Antiparasitic Compounds"
title_number: 0
title_name: "Federal Register"
section_number: "01-19763"
section_name: "Availability for Non-Exclusive, Exclusive, or Partially Exclusive Licensing of U.S. Patent Application Concern Antifungal and Antiparasitic Compounds"
positive_law: false
currency: "2001-08-07"
last_updated: "2001-08-07"
format_version: "1.1.0"
generator: "[email protected]"
agency: "Defense Department"
document_number: "01-19763"
document_type: "notice"
publication_date: "2001-08-07"
agencies:
  - "Defense Department"
  - "Army Department"
fr_citation: "66 FR 41210"
fr_volume: 66
fr_action: "Notice."
---

#  Availability for Non-Exclusive, Exclusive, or Partially Exclusive Licensing of U.S. Patent Application Concern Antifungal and Antiparasitic Compounds

**AGENCY:**

U.S. Army Medical Research and Material Command, DOD.

**ACTION:**

Notice.

**SUMMARY:**

In accordance with 37 CFR 404.6, announcement is made of the availability for licensing of U.S. Patent Application Serial No. 09/382.128 entitled “Antifungal and Antiparasitic Compounds” and filed August 24, 1999. This patent application has been assigned to the United States Government as represented by the Secretary of the Army.

**ADDRESSES:**

Commander, U.S. Army Medical Research and Material Command, ATTN: Command Judge Advocate, MCMR-JA, 504 Scott Street, Fort Detrick, Frederick, Maryland 21702-5012.

**FOR FURTHER INFORMATION CONTACT:**

For patent issues, Ms. Elizabeth Arwine, Patent Attorney, (301) 619-7808. For licensing issues, Dr. Paul Mele, Office of Research & Technology Assessment, (301) 619-6664. Both at telefax (301) 619-5034.

**SUPPLEMENTARY INFORMATION:**

Novel antiparasitic and antifungal compositions are disclosed. The antiparasitic and antifungal compositions are useful for human and veterinary therapy for the treatment and/or prevention of parasitic infection. Also disclosed are novel mechanisms of identifying antifungal and antiparasitic compositions by their biochemical action on lipid synethsis and/or metabolism and/or excretion.

Luz D. Ortiz,

Army Federal Register Liaison Officer.